Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Jurmala – page 18

211 clinical trials in Jurmala, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Jurmala at a glance
211
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

211 trials in Jurmala

Open in trial search

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Neoplasm

Not recruiting

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Merck Sharp & Dohme LLC

Macular oedema+1

Not recruiting

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Bronchiectasis

Not recruiting

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Avacincaptad Pegol
  • Sponsor:Astellas Pharma Global Development Inc.

Nephropathy

Not recruiting

Study on the Effects of Povetacicept for Adults with IgA Nephropathy

Investigational
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Alpine Immune Sciences Inc.

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Other cities in Latvia

The busiest research cities in the country

All 18 cities in Latvia

Clinical research in Jurmala

What the registry says about research in the country

01 Dermatology Research

Clinical investigations focusing on moderate to severe plaque psoriasis treatments, including innovative therapies aimed at providing long-term management solutions.

  • Long-term safety evaluations
  • Treatment efficacy assessment
  • Novel therapeutic approaches

Multiple trials are evaluating new treatment options to improve patient outcomes and quality of life.

02 Respiratory Medicine

Comprehensive research into respiratory conditions including asthma, COPD, and bronchiectasis, with trials exploring enhanced treatment strategies.

  • Asthma exacerbation management
  • COPD triple therapy studies
  • Bronchiectasis treatment safety

Studies focus on improving maintenance therapies and reducing disease exacerbations.

03 Cardiovascular Studies

Advanced research targeting atherosclerotic cardiovascular disease in end-stage kidney disease patients undergoing dialysis.

  • Inflammatory marker reduction
  • Cardiovascular outcomes
  • Dialysis patient care

Innovative approaches are being tested to address cardiovascular complications in ESKD patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.